scispace - formally typeset
Journal ArticleDOI

Self-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatients.

TLDR
In this small sample of VA patients with glaucoma, adherence to glAUcoma medications could be improved, especially among those who reported difficulties using their medications and those who were nonwhite.
Abstract
Objective: The purpose of the current study was to determine the self-reported prevalence of and factors associated with nonadherence with glaucoma medications in veteran outpatients. Methods: This survey study was conducted at a Veterans Affairs (VA) clinic. A survey was administered to patients with glaucoma. We calculated the percentage of self-reported adherence with glaucoma medications in each patient. Logistic regression was used to assess whether patient characteristics and difficulties with using glaucoma medications were related to patients' reporting that they were <100% adherent with their glaucoma medications in the previous week. Results: The survey was completed by 141 patients (men, 91.5%; mean [SD] age, 70.22 [11.60] years [range, 37–93 years]; black race, 45.4%; white race, 44.0%; “other” or data unavailable, 10.6%). Nonwhite patients were significantly less adherent in the previous week than were white patients (27.0% vs 11.3%; P < 0.05). A total of 67.4% patients reported ≥1 difficulty in using their glaucoma medications. The 3 most commonly reported difficulties were “drops fall on cheek” (29.1%), “too many drops come out” (20.6%), and “hard to read print” (17.0%). A total of 19.1% of patients self-reported using <100% of their glaucoma medications in the previous week. The number of difficulties reported was significantly associated with reporting being <100% adherent in the previous week (P<0.05). Conclusion: In this small sample of VA patients with glaucoma, adherence to glaucoma medications could be improved, especially among those who reported difficulties using their medications and those who were nonwhite.

read more

Citations
More filters
Journal ArticleDOI

The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.

TL;DR: Eye care providers need to assess patient adherence and to work with those patients with poor adherence to find ways to improve their ability and self-efficacy in using their glaucoma medications.
Journal Article

Does Adjunctive Glaucoma Therapy Affect Adherence to the Initial Primary Therapy

TL;DR: This statistically and clinically significant increase in refill intervals may affect intraocular pressure control and it is suggested that, when adding a second drug, physicians need to consider the possible impact on the patient's adherence to the first drug.
Journal ArticleDOI

Racial Differences in Medication Adherence: A Cross-Sectional Study of Medicare Enrollees

TL;DR: Elderly African Americans reported that they followed physician instructions on how to take medications less frequently than did elderly whites, even after adjusting for differences in demographic characteristics, health literacy, depression, and social support.
Journal ArticleDOI

Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma.

TL;DR: The results from this study indicate that cognitive impairment may be common in older patients with glaucoma, which has implications for treatment adherence, as difficulties in remembering information may significantly impede the ability to follow instructions from a physician.
Journal ArticleDOI

Update on the role of alpha-agonists in glaucoma management.

TL;DR: The use of apraclonidine for IOP reduction in glaucoma or OHT is limited due to a high rate of follicular conjunctivitis, and using brimonidine-timolol fixed combination (BTFC) as first-line therapy has an added potential for neuroprotection.
References
More filters
Journal ArticleDOI

The Ocular Hypertension Treatment Study: A Randomized Trial Determines That Topical Ocular Hypotensive Medication Delays or Prevents the Onset of Primary Open-Angle Glaucoma

TL;DR: Topical ocular hypotensive medication was effective in delaying or preventing the onset of POAG in individuals with elevated IOP, and clinicians should consider initiating treatment for individuals with ocular hypertension who are at moderate or high risk for developing POAG.
Journal ArticleDOI

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

TL;DR: The first adequately powered randomized trial with an untreated control arm to evaluate the effects of IOP reduction in patients with open-angle glaucoma who have elevated and normal IOP showed considerable beneficial effects of treatment that significantly delayed progression.
Journal ArticleDOI

Causes and prevalence of visual impairment among adults in the United States.

TL;DR: The prevalence of visual disabilities will increase markedly during the next 20 years, owing largely to the aging of the US population.
Journal ArticleDOI

The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration

TL;DR: In both analyses low intraocular pressure is associated with reduced progression of visual field defect, supporting evidence from earlier studies of a protective role for low intracular pressure in visual field deterioration.
Related Papers (5)